Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2008

Open Access 01-12-2008 | Study protocol

The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome

Authors: Johannes W Dietrich, Axel Stachon, Biljana Antic, Harald H Klein, Steffen Hering

Published in: BMC Endocrine Disorders | Issue 1/2008

Login to get access

Abstract

Background

Non-thyroidal illness syndrome (NTIS) is a characteristic functional constellation of thyrotropic feedback control that frequently occurs in critically ill patients. Although this condition is associated with significantly increased morbidity and mortality, there is still controversy on whether NTIS is caused by artefacts, is a form of beneficial adaptation, or is a disorder requiring treatment. Trials investigating substitution therapy of NTIS revealed contradictory results. The comparison of heterogeneous patient cohorts may be the cause for those inconsistencies.

Objectives

Primary objective of this study is the identification and differentiation of different functional states of thyrotropic feedback control in order to define relevant evaluation criteria for the prognosis of affected patients. Furthermore, we intend to assess the significance of an innovative physiological index approach (SPINA) in differential diagnosis between NTIS and latent (so-called "sub-clinical") thyrotoxicosis.
Secondary objective is observation of variables that quantify distinct components of NTIS in the context of independent predictors of evolution, survival or pathophysiological condition and influencing or disturbing factors like medication.

Design

The a pproach to a qua ntitative f ollow-up o f n on-t hyroidal i llness s yndrome (AQUA FONTIS study) is designed as both a cross-sectional and prospective longitudinal observation trial in critically ill patients. Patients are observed in at least two evaluation points with consecutive assessments of thyroid status, physiological and clinical data in additional weekly observations up to discharge. A second part of the study investigates the neuropsychological impact of NTIS and medium-term outcomes.
The study design incorporates a two-module structure that covers a reduced protocol in form of an observation trial before patients give informed consent. Additional investigations are performed if and after patients agree in participation.

Trial Registration

ClinicalTrials.gov NCT00591032
Appendix
Available only for authorised users
Literature
1.
go back to reference Berghe Van den G: Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 2002, 23: 370-391. 10.1016/S0091-3022(02)00006-7.CrossRefPubMed Berghe Van den G: Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 2002, 23: 370-391. 10.1016/S0091-3022(02)00006-7.CrossRefPubMed
2.
go back to reference De Groot LJ: Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006, 22: 57-86. 10.1016/j.ccc.2005.10.001.CrossRefPubMed De Groot LJ: Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006, 22: 57-86. 10.1016/j.ccc.2005.10.001.CrossRefPubMed
3.
go back to reference Rothenbuchner G, Loos U, Kiessling WR, Birk J, Pfeiffer EF: The influence of total starvation on the pituitary-thyroid-axis in obese individuals. Acta Endocrinol Suppl (Copenh). 1973, 173: 144- Rothenbuchner G, Loos U, Kiessling WR, Birk J, Pfeiffer EF: The influence of total starvation on the pituitary-thyroid-axis in obese individuals. Acta Endocrinol Suppl (Copenh). 1973, 173: 144-
4.
go back to reference Portnay GI, O'Brian JT, Bush J, Vagenakis AG, Azizi F, Arky RA, Ingbar SH, Braverman LE: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab. 1974, 39: 191-194.CrossRefPubMed Portnay GI, O'Brian JT, Bush J, Vagenakis AG, Azizi F, Arky RA, Ingbar SH, Braverman LE: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab. 1974, 39: 191-194.CrossRefPubMed
5.
go back to reference Chopra IJ: Nonthyroidal illness syndrome or euthyroid sick syndrome?. Endocr Pract. 1996, 2: 45-52.CrossRefPubMed Chopra IJ: Nonthyroidal illness syndrome or euthyroid sick syndrome?. Endocr Pract. 1996, 2: 45-52.CrossRefPubMed
6.
go back to reference Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L: Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003, 107: 708-713. 10.1161/01.CIR.0000048124.64204.3F.CrossRefPubMed Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L: Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003, 107: 708-713. 10.1161/01.CIR.0000048124.64204.3F.CrossRefPubMed
7.
go back to reference De Groot LJ: Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84: 151-164. 10.1210/jc.84.1.151.CrossRefPubMed De Groot LJ: Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84: 151-164. 10.1210/jc.84.1.151.CrossRefPubMed
8.
go back to reference Scoscia E, Baglioni S, Eslami A, Iervasi G, Monti S, Todisco T: Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol. 2004, 151: 557-560. 10.1530/eje.0.1510557.CrossRefPubMed Scoscia E, Baglioni S, Eslami A, Iervasi G, Monti S, Todisco T: Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol. 2004, 151: 557-560. 10.1530/eje.0.1510557.CrossRefPubMed
9.
go back to reference Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, Krieger KH: Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 1996, 61: 1323-1327. 10.1016/0003-4975(96)00102-6.CrossRefPubMed Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, Krieger KH: Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 1996, 61: 1323-1327. 10.1016/0003-4975(96)00102-6.CrossRefPubMed
10.
go back to reference Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K: Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995, 333: 1522-1527. 10.1056/NEJM199512073332302.CrossRefPubMed Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K: Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995, 333: 1522-1527. 10.1056/NEJM199512073332302.CrossRefPubMed
11.
go back to reference Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS: Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation. 2006, 114: I245-250.PubMed Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS: Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation. 2006, 114: I245-250.PubMed
13.
go back to reference Magalhaes AP, Gus M, Silva LB, Schaan BD: Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Braz J Med Biol Res. 2006, 39: 969-978. 10.1590/S0100-879X2006000700015.CrossRefPubMed Magalhaes AP, Gus M, Silva LB, Schaan BD: Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Braz J Med Biol Res. 2006, 39: 969-978. 10.1590/S0100-879X2006000700015.CrossRefPubMed
14.
go back to reference Guden M, Akpinar B, Saggbas E, Sanisoglu I, Cakali E, Bayindir O: Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann. 2002, 10: 219-222.CrossRefPubMed Guden M, Akpinar B, Saggbas E, Sanisoglu I, Cakali E, Bayindir O: Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann. 2002, 10: 219-222.CrossRefPubMed
15.
go back to reference Ronald A, Dunning J: Does perioperative thyroxine have a role during adult cardiac surgery?. Interact Cardiovasc Thorac Surg. 2006, 5: 166-178. 10.1510/icvts.2006.128363.CrossRefPubMed Ronald A, Dunning J: Does perioperative thyroxine have a role during adult cardiac surgery?. Interact Cardiovasc Thorac Surg. 2006, 5: 166-178. 10.1510/icvts.2006.128363.CrossRefPubMed
16.
go back to reference Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP: A trial of thyroxine in acute renal failure. Kidney Int. 2000, 57: 293-298. 10.1046/j.1523-1755.2000.00827.x.CrossRefPubMed Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP: A trial of thyroxine in acute renal failure. Kidney Int. 2000, 57: 293-298. 10.1046/j.1523-1755.2000.00827.x.CrossRefPubMed
17.
go back to reference Brent GA, Hershman JM: Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986, 63: 1-8.CrossRefPubMed Brent GA, Hershman JM: Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986, 63: 1-8.CrossRefPubMed
18.
go back to reference Utiger RD: Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?. N Engl J Med. 1995, 333: 1562-1563. 10.1056/NEJM199512073332310.CrossRefPubMed Utiger RD: Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?. N Engl J Med. 1995, 333: 1562-1563. 10.1056/NEJM199512073332310.CrossRefPubMed
19.
go back to reference Caplan RH: Comment on dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84: 2261-2262. 10.1210/jc.84.6.2261-a.CrossRefPubMed Caplan RH: Comment on dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84: 2261-2262. 10.1210/jc.84.6.2261-a.CrossRefPubMed
20.
go back to reference Angstwurm MW, Schopohl J, Gaertner R: Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol. 2004, 151: 47-54. 10.1530/eje.0.1510047.CrossRefPubMed Angstwurm MW, Schopohl J, Gaertner R: Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol. 2004, 151: 47-54. 10.1530/eje.0.1510047.CrossRefPubMed
21.
go back to reference Dietrich JW, Fischer MR, Jauch J, Pantke E, Gärtner R, Pickardt CR: SPINA-THYR: A novel systems theoretic approach to determine the secretion capacity of the thyroid gland. European Journal of Internal Medicine. 1999, 10 (Suppl 1): S34- Dietrich JW, Fischer MR, Jauch J, Pantke E, Gärtner R, Pickardt CR: SPINA-THYR: A novel systems theoretic approach to determine the secretion capacity of the thyroid gland. European Journal of Internal Medicine. 1999, 10 (Suppl 1): S34-
23.
go back to reference Burch HB, Wartofsky L: Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993, 22: 263-277.PubMed Burch HB, Wartofsky L: Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993, 22: 263-277.PubMed
24.
go back to reference Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, Refetoff S: Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab. 1999, 84: 3919-3928. 10.1210/jc.84.11.3919.PubMed Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, Refetoff S: Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab. 1999, 84: 3919-3928. 10.1210/jc.84.11.3919.PubMed
25.
go back to reference Graham JW: Missing Data Analysis: Making It Work in the Real World. Annu Rev Psychol. 2008 Graham JW: Missing Data Analysis: Making It Work in the Real World. Annu Rev Psychol. 2008
26.
go back to reference Druml C: Informed consent of incapable (ICU) patients in Europe: existing laws and the EU Directive. Curr Opin Crit Care. 2004, 10: 570-573. 10.1097/01.ccx.0000144765.73540.89.CrossRefPubMed Druml C: Informed consent of incapable (ICU) patients in Europe: existing laws and the EU Directive. Curr Opin Crit Care. 2004, 10: 570-573. 10.1097/01.ccx.0000144765.73540.89.CrossRefPubMed
27.
go back to reference Jansen TC, Kompanje EJ, Druml C, Menon DK, Wiedermann CJ, Bakker J: Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not?. Intensive Care Med. 2007, 33: 894-900. 10.1007/s00134-007-0580-8.CrossRefPubMedPubMedCentral Jansen TC, Kompanje EJ, Druml C, Menon DK, Wiedermann CJ, Bakker J: Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not?. Intensive Care Med. 2007, 33: 894-900. 10.1007/s00134-007-0580-8.CrossRefPubMedPubMedCentral
28.
go back to reference Anonymous: Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz – AMG). BGBl. 2007, I: 1066- Anonymous: Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz – AMG). BGBl. 2007, I: 1066-
29.
go back to reference Anonymous: Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities. 2001, L 121: 33-44. Anonymous: Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities. 2001, L 121: 33-44.
30.
go back to reference Anonymous: Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Off J Eur Union. 2005, L 91: 13-19. Anonymous: Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Off J Eur Union. 2005, L 91: 13-19.
31.
go back to reference Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007, 4: e297-10.1371/journal.pmed.0040297.CrossRefPubMedPubMedCentral Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007, 4: e297-10.1371/journal.pmed.0040297.CrossRefPubMedPubMedCentral
32.
go back to reference Iwanowski P, Budaj A, Czlonkowska A, Wasek W, Kozlowska-Boszko B, Oledzka U, Maselbas W: Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes. Trials. 2008, 9: 45-10.1186/1745-6215-9-45.CrossRefPubMedPubMedCentral Iwanowski P, Budaj A, Czlonkowska A, Wasek W, Kozlowska-Boszko B, Oledzka U, Maselbas W: Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes. Trials. 2008, 9: 45-10.1186/1745-6215-9-45.CrossRefPubMedPubMedCentral
Metadata
Title
The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome
Authors
Johannes W Dietrich
Axel Stachon
Biljana Antic
Harald H Klein
Steffen Hering
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2008
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-8-13

Other articles of this Issue 1/2008

BMC Endocrine Disorders 1/2008 Go to the issue